Michele Ceribelli

Also affiliated with National Cancer Institute, National Center for Advancing Translational Sciences, National Blood Clot Alliance

Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.8Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

Cancer Research(2023)10.1158/0008-5472.can-22-2996

Top 23%

0.862DataRank

Top 23%32 citations

Kelli M. Wilson, Fathi Elloumi, Katie R. Bradwell, Michele Ceribelli, Sudhir Varma +12 more

Papers

Driven by 30 papers — median percentile 59. Top paper: “Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress”.

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Cancer Cell(2021)10.1016/j.ccell.2021.02.014

N/A

4.8DataRank · unranked

178 citations

Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli +36 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1401

N/A

0.917DataRank · unranked

28 citations

Jiji Chen, Jiamin Liu, Frank Schnütgen, Julius C. Enßle, Michele Ceribelli +24 more

CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

Cancer Research(2023)10.1158/0008-5472.can-22-2996

Top 23%

0.862DataRank

Top 23%32 citations

Kelli M. Wilson, Fathi Elloumi, Katie R. Bradwell, Michele Ceribelli, Sudhir Varma +12 more

Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics

Cell Systems(2023)10.1016/j.cels.2023.05.003

N/A

0.711DataRank · unranked

16 citations

Aleksandra M. Michalowski, Michele Ceribelli, Joachim De Jonghe, Maria Vias, Deanna Riley +12 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0.619DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

A landscape of response to drug combinations in non-small cell lung cancer

Nature Communications(2023)10.1038/s41467-023-39528-9

N/A

0.604DataRank · unranked

55 citations

Patricia Greninger, Xiaohu Zhang, Adam Friedman, Arnaud Amzallag, Eliane Cortez +25 more

Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas

Cancer Cell(2024)10.1016/j.ccell.2024.04.007

N/A

0.505DataRank · unranked

28 citations

Michele Ceribelli, James D. Phelan, Björn Häupl, Da Wei Huang, George W. Wright +19 more

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

Nature Communications(2022)10.1038/s41467-022-33142-x

N/A

0.494DataRank · unranked

26 citations

Arnold Bolomsky, Thomas Oellerich, Ping Chen, Michele Ceribelli, Björn Häupl +21 more

An optimal set of inhibitors for Reverse Engineering via Kinase Regularization

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.26.312348

Top 41%

0.457DataRank

Top 41%17 citations

Jonathan Scott Gruver, Natalia Trikoz, Alexander A. Lukyanov, Janelle S. Vultaggio, Michele Ceribelli +5 more

High-throughput approaches to uncover synergistic drug combinations in leukemia

SLAS DISCOVERY(2023)10.1016/j.slasd.2023.04.004

Top 42%

0.446DataRank

Top 42%9 citations

Meng Wang, Michele Ceribelli, Aleksandra M. Michalowska, Stefan Golas, Erin Beck +13 more

Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0085

N/A

0.396DataRank · unranked

13 citations

Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas +18 more

Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02416-z

N/A

0.396DataRank · unranked

13 citations

Janhavi Dubhashi, Anand Singh, Parthav Jailwala, Alexei Lobanov, Craig J. Thomas +10 more

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0225

N/A

0.345DataRank · unranked

9 citations

Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia Ileva +25 more

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2413372121

N/A

0.330DataRank · unranked

8 citations

Frances A. Tosto, Xiaohu Zhang, Christopher Melani, Mark Roschewski, Erin Beck +13 more

Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization

Leukemia(2025)10.1038/s41375-025-02695-3

N/A

0.312DataRank · unranked

7 citations

Aishlin Hassan, Kwangmin Choi, Joshua Bennett, Tomoya Muto, Courtnee Clough +13 more

Genome-wide Screens Identify Lineage- and Tumor Specific-Genes Modulating MHC-I and MHC-II Immunosurveillance in Human Lymphomas

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.13.989558

N/A

0.165DataRank · unranked

2 citations

James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Hollý +14 more

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML

Leukemia(2025)10.1038/s41375-025-02842-w

N/A

0.165DataRank · unranked

2 citations

Warren Fiskus, Christopher P. Mill, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo +13 more

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412

N/A

0.165DataRank · unranked

2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological Oncology(2023)10.1002/hon.3164_437

N/A

0.104DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, J. D. Phelan, Y. Yang, Theresa Davies‐Hill +17 more

Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c01027

N/A

0DataRank · unranked

0 citations

Damien Duveau, Michele Ceribelli, Frances Anne Tosto, Dara N. Love, Bridget S. Scherer +9 more

KiRNet: Kinase-centered network propagation of pharmacological screen results

Cell Reports Methods(2021)10.1016/j.crmeth.2021.100007

N/A

0DataRank · unranked

19 citations

Marina Chan, Martin Golkowski, Andrew G. Xue, Nithisha Khasnavis, Michele Ceribelli +4 more

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.28.470260

N/A

0DataRank · unranked

1 citations

Thomas Oellerich, Ping Chen, Arnold Bolomsky, Michele Ceribelli, Björn Häupl +21 more

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101244

N/A

0DataRank · unranked

25 citations

Simone Lubrano, Michele Ceribelli, Damiano Cosimo Rigiracciolo, Robert Saddawi‐Konefka, Farhoud Faraji +18 more

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

Cancers(2023)10.3390/cancers15164034

N/A

0DataRank · unranked

13 citations

Adam Cheuk, Kristine A. Isanogle, Christina M. Robinson, Xiaohu Zhang, Michele Ceribelli +22 more

Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0552

N/A

0DataRank · unranked

11 citations

Michele Ceribelli, Haiqing Fu, Christophe E. Redon, Ukhyun Jo, Yasuhisa Murai +4 more

Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma

Pharmaceuticals(2023)10.3390/ph16121635

N/A

0DataRank · unranked

11 citations

Patrick J. Morris, Craig J. Thomas, Michele Ceribelli, Lale Evsen

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

Cancer Cell(2024)10.1016/j.ccell.2024.05.026

N/A

0DataRank · unranked

35 citations

Michele Ceribelli, Sebastian Scheich, Kristina Rinaldi, Da Wei Huang, Papiya Chakraborty +16 more

Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0096

N/A

0DataRank · unranked

4 citations

Andres F. Leon, Erica L. Beatson, Jessica D. Kindrick, Kinjal Bhadresha, Xiaohu Zhang +15 more

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

Immunity(2020)10.1016/j.immuni.2020.11.002

N/A

0DataRank · unranked

143 citations

James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Hollý +14 more

Michele Ceribelli

Indexed papers

Top data-sharing exemplar

Papers